Search by...
-
31MayProcessing health data on online platforms: The Garante rules on fairnessWith order no. 368 of November 10, 2022, the Italian Data Protection Authority ruled that the provider of an online platform aimed at connecting healthcare professionals with patients was in breach of the personal data protection rules provided by the GDPR in processing data via their platform.
-
-
22MayIntelligenza artificiale in azienda: le sfide della complianceIn qualsiasi settore si cerca di trarre valore dai dati personali che vengono trattati o di offrire servizi innovativi e personalizzati, e spesso lo si fa utilizzando l’IA. Questo pone importanti sfide in ambito privacy
-
-
12MayDrug advertising: New directions from EuropeEurope is not making any revolutionary changes when it comes to the advertising of medicines.
-
-
26AprThe metaverse in healthcare: What are the legal implications?Di fronte a così tante opportunità, il diritto si interroga su quali possano essere gli strumenti per gestire e regolare il fenomeno del metaverso nella sanità.
-
-
17AprDelivering drugs to the public outside a pharmacy via a third party: Considerations on a recent ruling by the Criminal Court of CassationIt’s official: Under certain conditions it is not an offense for drugs—including prescription drugs—to be received by and distributed to the public, potentially even outside the pharmacy channel.
-
-
28MarDecentralized clinical trials: Recommendation paper for the implementation of uniform procedures in the European Union publishedOn December 13, the European Commission (EC), the Heads of Medicines Agencies (HMAs), and the European Medicines Agency (EMA) published a document entitled Recommendation paper on decentralised elements in clinical trials (“Recommendations”) to provide Member States further and more detailed guidance on the implementation of procedures for conducting trials outside of traditional clinical trial centers.
-
-
24FebIn the United States, Amazon launched RxPass, a subscription for online purchase of prescription drugs: Could it work in Italy?A few weeks ago, the company introduced a new subscription service that allows subscribers to purchase more than fifty different prescription medicines for a low fixed months fee. Why this would be prohibited in Italy.
-
-
25JanHow Covid changed telemedicine in Italy: Current status and next stepsDurante e dopo la pandemia, la telemedicina è stata al centro di una serie di importanti interventi del legislatore. A questi si aggiungono ora i fondi del PNRR per 1 mld di euro. Tali risorse e il ruolo delle regioni nel garantirne l’implementazione saranno di fondamentale importanza.
-
-
21DecClinical trials and sanctions in relation to Regulation 2014/536, national rules, and contract standardsThe European rules on drug trials do not include provisions for sanctions, but instead leave it up to Member States to outline an effective sanctioning framework.
-
-
1DecReuse of personal data for research purposes in light of the most recent guidelines from the GaranteIn the context of clinical studies, companies are concerned about the legal conditions for use for research purposes of previously collected personal data, including data from third parties.
-
